Literature DB >> 28628948

Platelet hyperaggregability is associated with decreased ADAMTS13 activity and enhanced endotoxemia in patients with acute cholangitis.

Hiroaki Takaya1, Hideto Kawaratani1, Takuya Kubo1, Kenichiro Seki1, Yasuhiko Sawada1, Kosuke Kaji1, Yasushi Okura1, Kosuke Takeda1, Mitsuteru Kitade1, Kei Moriya1, Tadashi Namisaki1, Akira Mitoro1, Masanori Matsumoto2, Hiroshi Fukui1, Hitoshi Yoshiji1.   

Abstract

AIM: Insufficient ADAMTS13 activity (ADAMTS13:AC) leads to increased levels of unusually large von Willebrand factor (VWF) multimers and causes microcirculatory disturbance and multiple organ failure (MOF). Endotoxin (Et) triggers the activation of coagulation and cytokine cascades, leading to MOF in severe inflammatory response syndrome. Here, we investigated the potential role of endotoxemia-related ADAMTS13 in acute cholangitis.
METHODS: Twenty-four patients with acute cholangitis, including 7 with severe acute cholangitis, were recruited in this study. The levels of ADAMTS13:AC, VWF antigen (VWF:Ag), interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α in each patient were determined by enzyme-linked immunosorbent assay, whereas Et levels were determined by Et activity assay (EAA) analysis.
RESULTS: The ADAMTS13:AC and VWF:Ag levels were significantly lower and higher, respectively, in patients with acute cholangitis than in controls. The EAA levels were higher in patients with acute cholangitis than in controls, and were inversely correlated with that of ADAMTS13:AC. Patients with severe acute cholangitis had significantly lower ADAMTS13:AC and higher VWF:Ag levels than those with mild to moderate cholangitis. Notably, ADMTS13:AC was directly correlated with platelet counts and inversely correlated with IL-6 levels, and the VWF:Ag/ADAMTS13:AC ratio was directly correlated with IL-8 and TNF-α levels.
CONCLUSIONS: Imbalance of ADAMTS13:AC and VWF:Ag levels might be associated with severe acute cholangitis, reflecting platelet hyperaggregability. Severe acute cholangitis has severe pathophysiological features and is complicated by endotoxemia and MOF. Notably, this is the first report indicating an association between the levels of ADAMTS13:AC and VWF:Ag and those of EAA and cytokines in acute cholangitis.
© 2017 The Japan Society of Hepatology.

Entities:  

Keywords:  ADAMTS13; EAA; VWF; acute cholangitis; cytokine; endotoxin

Year:  2017        PMID: 28628948     DOI: 10.1111/hepr.12926

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  5 in total

1.  Increased Endotoxin Activity Is Associated with the Risk of Developing Acute-on-Chronic Liver Failure.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Shinya Sato; Kosuke Kaji; Yuki Tsuji; Daisuke Kaya; Yukihisa Fujinaga; Yasuhiko Sawada; Naotaka Shimozato; Hideto Kawaratani; Kei Moriya; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  J Clin Med       Date:  2020-05-14       Impact factor: 4.241

2.  VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Mitsuteru Kitade; Kosuke Kaji; Keisuke Nakanishi; Yuki Tsuji; Naotaka Shimozato; Kei Moriya; Kenichiro Seki; Yasuhiko Sawada; Soichiro Saikawa; Shinya Sato; Hideto Kawaratani; Takemi Akahane; Ryuichi Noguchi; Masanori Matsumoto; Hitoshi Yoshiji
Journal:  BMC Gastroenterol       Date:  2019-10-21       Impact factor: 3.067

3.  Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Kei Moriya; Naotaka Shimozato; Kosuke Kaji; Hiroyuki Ogawa; Koji Ishida; Yuki Tsuji; Daisuke Kaya; Hirotestu Takagi; Yukihisa Fujinaga; Norihisa Nishimura; Yasuhiko Sawada; Hideto Kawaratani; Takemi Akahane; Masanori Matsumoto; Hitoshi Yoshiji
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

4.  ADAMTS13, VWF, and Endotoxin Are Interrelated and Associated with the Severity of Liver Cirrhosis via Hypercoagulability.

Authors:  Hiroaki Takaya; Tadashi Namisaki; Shohei Asada; Satoshi Iwai; Takahiro Kubo; Junya Suzuki; Masahide Enomoto; Yuki Tsuji; Yukihisa Fujinaga; Norihisa Nishimura; Yasuhiko Sawada; Kosuke Kaji; Hideto Kawaratani; Kei Moriya; Takemi Akahane; Masanori Matsumoto; Hitoshi Yoshiji
Journal:  J Clin Med       Date:  2022-03-26       Impact factor: 4.241

Review 5.  Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus.

Authors:  Upendra K Katneni; Aikaterini Alexaki; Ryan C Hunt; Tal Schiller; Michael DiCuccio; Paul W Buehler; Juan C Ibla; Chava Kimchi-Sarfaty
Journal:  Thromb Haemost       Date:  2020-08-24       Impact factor: 5.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.